Skip to main content

Atrium Therapeutics, Inc.

corporate_fare Company Profile

Atrium Therapeutics, Inc.

RNA·NASDAQ·Life Sciences·CIK 0002093101

Atrium Therapeutics, Inc. is a biopharmaceutical company that develops RNA-based therapies specifically for heart conditions, aiming to change how cardiomyopathies are treated. The company's current product candidates in development include ATR 1072, which is a siRNA-based therapy designed to target PRKAG2 for the treatment of PRKAG2 syndrome. Another candidate is ATR 1086, also a siRNA-based therapy, which targets PLN for the treatment of PLN cardiomyopathy. Atrium Therapeutics also has a broader pipeline focused on treating various genetic and cardiac diseases. The company was incorporated in 2025 and operates from its headquarters in San Diego, California.

Atrium Therapeutics, Inc. (NASDAQ:RNA) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 21 items for RNA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-12, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 10/10, with 14 rated 8 or above. Recent SEC coverage for RNA spans 8-K, 10-Q, 10-K, DEFA14A.

Recent high-impact activity:

  • Atrium Therapeutics Posts 25-Cent Quarterly Loss as Cash Burn Draws Scrutiny
  • Activist Yakira Demands Strategic Review at Atrium, Says Stock Trades Below Net Cash
  • Atrium Therapeutics Prices $50M PIPE at $7.93/Share, Extends Runway Through 2028
  • Atrium Therapeutics Raises $50M in Private Placement Near 52-Week Low
  • FDA Clears Atrium's IND for ATR 1072, Phase 1/2 Trial to Start

Short Interest & Short Volume

16.07 days to cover

FINRA reported short interest of 3,749,186 shares in RNA as of the October 30, 2026 settlement, a 0.6% increase from the prior period — about 16.1 days to cover at its recent average daily volume. On November 20, 2026, 62.5% of RNA volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)3,749,186 shares as of October 30, 2026
Change vs prior period▲ 0.6%
Days to cover16.07 at avg daily volume of 233,325
Daily short volume (FINRA facilities)62.5% of 117,672 shares on November 20, 2026
5-day average short volume49.7%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Moderate risk

Filing-implied dilution signals for RNA, detected from its recent SEC filings · based on capital-structure filings through 2026-10-09.

ATM program

Post-Offering Share Count Corrected · PIPE Terms Reaffirmed

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with R →
$6.92
52-week range · as of 2026-10-08 $6.92 – $16.77
Market cap
$149.27M
Volume
319.7K (1.4× avg)
3-mo avg 228.9K
Live data · 2026-11-21 08:06 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed RNA - Latest Insights

RNA
Nov 12, 2026, 4:10 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $7.56
Real-time Price: $6.92 info
Change: -$0.640 (-8%) info
Market Cap: $149.275M info
RNA
Oct 20, 2026, 8:09 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $7.72
Real-time Price: $6.92 info
Change: -$0.800 (-10%) info
Market Cap: $149.275M info
RNA
Oct 08, 2026, 6:52 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.93
Real-time Price: $6.92 info
Change: -$1.01 (-13%) info
Market Cap: $149.275M info
RNA
Oct 08, 2026, 6:30 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $7.93
Real-time Price: $6.92 info
Change: -$1.01 (-13%) info
Market Cap: $149.275M info
RNA
Jul 14, 2026, 5:23 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $12.22
Real-time Price: $6.92 info
Change: -$5.30 (-43%) info
Market Cap: $149.275M info
RNA
Jul 14, 2026, 5:14 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $12.22
Real-time Price: $6.92 info
Change: -$5.30 (-43%) info
Market Cap: $149.275M info
RNA
May 14, 2026, 4:53 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $13.27
Real-time Price: $6.92 info
Change: -$6.35 (-48%) info
Market Cap: $149.275M info
RNA
May 14, 2026, 4:51 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $13.27
Real-time Price: $6.92 info
Change: -$6.35 (-48%) info
Market Cap: $149.275M info
RNA
May 14, 2026, 4:50 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $13.27
Real-time Price: $6.92 info
Change: -$6.35 (-48%) info
Market Cap: $149.275M info
RNA
Feb 27, 2026, 9:13 AM EST
Filing Type: 8-K
Importance Score:
10
Price at Filing: $15.30
Real-time Price: $6.92 info
Change: -$8.38 (-55%) info
Market Cap: $149.275M info
RNA
Feb 27, 2026, 9:03 AM EST
Source: Reuters
Importance Score:
9
Price at Filing: $15.24
Real-time Price: $6.92 info
Change: -$8.32 (-55%) info
Market Cap: $149.275M info
RNA
Feb 26, 2026, 4:58 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $72.77
Real-time Price: $6.92 info
Change: -$65.85 (-90%) info
Market Cap: $149.275M info
RNA
Feb 23, 2026, 4:04 PM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $72.92
Real-time Price: $6.92 info
Change: -$66.00 (-91%) info
Market Cap: $149.275M info
RNA
Feb 23, 2026, 8:30 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $72.86
Real-time Price: $6.92 info
Change: -$65.94 (-91%) info
Market Cap: $149.275M info
RNA
Feb 18, 2026, 8:51 AM EST
Filing Type: DEFA14A
Importance Score:
8
Price at Filing: $72.93
Real-time Price: $6.92 info
Change: -$66.01 (-91%) info
Market Cap: $149.275M info
RNA
Feb 13, 2026, 4:15 PM EST
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $72.70
Real-time Price: $6.92 info
Change: -$65.78 (-90%) info
Market Cap: $149.275M info
RNA
Feb 03, 2026, 7:00 AM EST
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $72.74
Real-time Price: $6.92 info
Change: -$65.82 (-90%) info
Market Cap: $149.275M info
RNA
Jan 30, 2026, 4:37 PM EST
Filing Type: DEFM14A
Importance Score:
9
Price at Filing: $72.57
Real-time Price: $6.92 info
Change: -$65.65 (-90%) info
Market Cap: $149.275M info
RNA
Jan 14, 2026, 4:01 PM EST
Filing Type: DFAN14A
Importance Score:
10
Price at Filing: $72.54
Real-time Price: $6.92 info
Change: -$65.62 (-90%) info
Market Cap: $149.275M info
RNA
Jan 12, 2026, 4:35 PM EST
Filing Type: DFAN14A
Importance Score:
9
Price at Filing: $72.35
Real-time Price: $6.92 info
Change: -$65.43 (-90%) info
Market Cap: $149.275M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets